Charles Robert Harrington
31Patents
8h-index
37Co-inventors
75Inventor score
Filing activity: Dec 12, 1997 → Mar 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6953794B2 | Inhibition of tau-tau association | Physics | 50 | Expired |
| US9283230B2 | Phenothiazine diaminium salts and their use | Emerging Cross-Sectional Technologies | 28 | Active |
| US6376205B1 | Screening methods for agents that modulate or inhibit tau association with tau or map2 | Physics | 15 | Expired |
| US7737138B2 | Methods of treatment of a tauopathy condition comprising the use of thioninium compounds | Chemistry; Metallurgy | 12 | Active |
| US8710051B2 | 3,7-diamino-10H-phenothiazine salts and their use | Emerging Cross-Sectional Technologies | 8 | Active |
| US7834237B2 | Materials and methods relating to protein aggregation in neurodegenerative disease | Physics | 8 | Expired |
| US9149481B2 | Therapeutic use of diaminophenothiazines | Human Necessities | 8 | Active |
| US7888350B2 | 3,7-diamino-10H-phenothiazine salts and their use | Emerging Cross-Sectional Technologies | 8 | Active |
| US7335652B2 | Neurofibrillary labels | Physics | 7 | Expired |
| US7605179B2 | Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders | Human Necessities | 7 | Expired |
| US8263589B2 | Inhibitors of protein aggregation | Emerging Cross-Sectional Technologies | 7 | Active |
| US7713962B2 | Neurofibrillary labels | Physics | 7 | Active |
| US11344558B2 | 3, 7-diamino-10H-phenothiazine salts and their use | Emerging Cross-Sectional Technologies | 6 | Active |
| US7534786B2 | Inhibition of tau-tau association | Physics | 6 | Active |
| US10188658B2 | Therapeutic use of diaminophenothiazines | Human Necessities | 5 | Active |
| US11180464B2 | Phenothiazine diaminium salts and their use | Emerging Cross-Sectional Technologies | 5 | Active |
| US7335505B2 | Materials and methods relating to protein aggregation in neurodegenerative disease | Human Necessities | 5 | Expired |
| US10864216B2 | Phenothiazine diaminium salts and their use | Emerging Cross-Sectional Technologies | 5 | Active |
| US8278298B2 | Inhibition of tau-tau-association | Physics | 3 | Active |
| US9174954B2 | 3,7-diamino-10H-phenothiazine salts and their use | Emerging Cross-Sectional Technologies | 3 | Active |
| US8475808B2 | Immunogenic reagents from west nile virus | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9549933B2 | 3,6-disubstituted xanthylium salts | Physics | 1 | Active |
| US11951110B2 | 3, 7-diamino-10H-phenothiazine salts and their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US9907804B2 | Phenothiazine diaminium salts and their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US8658665B2 | 3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.